R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

Peter MacCallum Cancer Centre, East Melbourne, Australia;University of Melbourne, Parkville, Australia
Saarland University Hospital, Homburg, Germany
General Hospital, Charles University First Faculty of Medicine, Prague, Czech Republic
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Canada
Frankston Hospital and Monash University, Frankston, Australia
F. Hoffmann-La Roche Ltd. Pharmaceuticals Division, PDCO, Basel, Switzerland
F. Hoffmann-La Roche Ltd. Pharmaceuticals, Biostatistics, Basel, Switzerland
Centre Hospitalier Lyon-Sud, Lyon, France
Vol. 99 No. 8 (2014): August, 2014